| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/06/1990 | US4898830 Glandular disorders; gene expression and construction |
| 02/06/1990 | US4898828 Antibiotic resistance |
| 02/06/1990 | US4898823 Increasing expression level of a yeast expression vector; upstream activator sequence from yeast pkg gene |
| 02/06/1990 | US4898818 Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism |
| 02/06/1990 | US4898814 A cDNA clone for human tyrosinase |
| 02/06/1990 | EP0318487A4 Serum free tissue culture medium containing polymeric cell-protective agent. |
| 02/06/1990 | CA1265650A1 Method for purifying a physiologically active substance produced by recombinant dna technique |
| 02/06/1990 | CA1265462A1 Antibiotic a42125 and process for its production |
| 02/01/1990 | DE3923085A1 Phosphinothricin-resistance gene effective in plants, and its use |
| 02/01/1990 | DE3825948A1 System for detecting the activity of gene expression control elements |
| 01/31/1990 | EP0353191A2 DNA sequences encoding polypeptides having beta-1,3-glucanase activity |
| 01/31/1990 | EP0353188A2 Novel expression system |
| 01/31/1990 | EP0353150A1 Recombinant non-glycosylated human IL2 in reduced form, process for its production and its medical use |
| 01/31/1990 | EP0353111A1 Nucleic acid or fragments thereof encoding the P30 protein of Toxoplasma gondii, methods for their preparation and uses thereof |
| 01/31/1990 | EP0352904A1 Tissue plasminogen activator analogues |
| 01/31/1990 | EP0352894A2 Production of cosmetic or pharmaceutical composition |
| 01/31/1990 | EP0352839A2 Process for producing hEGF |
| 01/31/1990 | EP0352763A1 DNA fragment containing gene which encodes the function of stabilizing plasmid in host microorganism |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352710A2 t-PA derivative and its production |
| 01/31/1990 | EP0352707A2 An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
| 01/31/1990 | EP0352651A1 Human protein C mutants and method for preparing the same |
| 01/31/1990 | EP0352387A1 Method for preparing a hirudin |
| 01/31/1990 | EP0352328A1 Human monoclonal antibody against aspergilli |
| 01/30/1990 | US4897471 Consensus human leukocyte interferon |
| 01/30/1990 | US4897355 Lipisome-polyanion complex |
| 01/30/1990 | US4897348 Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
| 01/30/1990 | CA1265077A1 Hybrid proteins produced by an ultrahigh prokaryotic expression system |
| 01/25/1990 | WO1990000626A1 Solid phase assembly and reconstruction of biopolymers |
| 01/25/1990 | WO1990000624A1 Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| 01/25/1990 | WO1990000617A1 Antibodies specific towards gp 48 |
| 01/25/1990 | WO1990000614A1 Receptor specific proteins and their use in receptor typing |
| 01/25/1990 | WO1990000612A1 Production of chemical compounds |
| 01/25/1990 | WO1990000611A1 Synthesis of stereospecific enzyme by non-chromosomal transformation of a host |
| 01/25/1990 | WO1990000610A1 New expression vectors |
| 01/25/1990 | WO1990000609A1 Cellulose binding fusion proteins |
| 01/25/1990 | WO1990000608A1 Positive selection system for stabilisation of expression vectors |
| 01/25/1990 | WO1990000607A2 Gap gene sequences and diagnostic uses thereof |
| 01/25/1990 | WO1990000606A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 01/25/1990 | WO1990000605A1 Methods and means for controlling the stability of proteins |
| 01/25/1990 | WO1990000604A1 Transformed shigella |
| 01/25/1990 | WO1990000603A1 New polynucleotide sequences |
| 01/25/1990 | WO1990000601A2 Novel glucose isomerase enzymes and their use |
| 01/25/1990 | WO1990000600A1 A tissue plasminogen activator analogue |
| 01/25/1990 | WO1990000599A1 Uses of viral enzymes |
| 01/25/1990 | WO1990000598A1 Purification and administration of dna repair enzymes |
| 01/25/1990 | WO1990000594A2 Recombinant mycobacterial expression vehicles and uses therefor |
| 01/25/1990 | WO1990000569A1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 01/25/1990 | WO1990000565A1 Interleukin ii analogs |
| 01/25/1990 | WO1990000563A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
| 01/25/1990 | WO1990000558A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 01/25/1990 | WO1990000556A1 Synthetic hiv protease gene and method for its expression |
| 01/25/1990 | WO1990000403A1 Genetically engineered coccidiosis vaccine |
| 01/25/1990 | WO1990000400A1 Tumor necrosis enhancing factor and methods of preparation and use |
| 01/24/1990 | EP0352250A2 Bordetella pertussis vaccine |
| 01/24/1990 | EP0352228A2 Novel proteins |
| 01/24/1990 | EP0352227A2 Modified proteins |
| 01/24/1990 | EP0352119A2 Vampire bat salivary plasminogen activators |
| 01/24/1990 | EP0352089A2 A modified human PSTI |
| 01/24/1990 | EP0352073A1 Vectors, cells transformed thereby, and their use in producing heterologous polypeptides |
| 01/24/1990 | EP0352060A2 Expression plasmid and use thereof |
| 01/24/1990 | EP0352024A1 Production of chemical compounds |
| 01/24/1990 | EP0351944A1 Monoclonal antibodies to immunogenic human interleukin-3 peptide |
| 01/24/1990 | EP0351924A2 Improvements relating to transgenic plants |
| 01/24/1990 | EP0351921A2 Modified beta adrenergic receptor |
| 01/24/1990 | EP0351826A2 DNA encoding an anticoagulant polypeptide |
| 01/24/1990 | EP0351789A2 Improved monoclonal antibodies reactive with cachectin |
| 01/24/1990 | EP0351731A2 Monoclonal antibodies capable of recognizing gangliosides GQ1b and GT1a |
| 01/24/1990 | EP0351717A2 Plasmid for production of alpha-amylase in Bacillus |
| 01/24/1990 | EP0351604A1 Neisserial vaccines |
| 01/24/1990 | EP0351586A1 Plasmids containing a chicken beta-actin promoter and a human factor VIII:C gene, transformants and processes for preparing human factor VIII:C |
| 01/24/1990 | EP0351585A2 Vector containing a chicken beta-actin gene promoter for the expression of a desired gene |
| 01/24/1990 | EP0351575A2 D-HicDH-gene, preparation of D-HicDH and its use |
| 01/24/1990 | EP0351427A1 Bacillus cells |
| 01/24/1990 | EP0323959A4 PROTEINE PROTEASE INHIBITORS FROM -i(STREPTOMYCES). |
| 01/23/1990 | US4895805 Cell manipulating apparatus |
| 01/23/1990 | US4895802 DNA strand coding for α-acetolactate decarboxylase and yeast transformed with the DNA strand |
| 01/23/1990 | US4895800 Biosynthesis, pichia, genetic engineering |
| 01/23/1990 | US4895796 Natural killer cells, two different labeled reagents |
| 01/23/1990 | US4895795 Detection and differentiation of coxiella burnetii in biological fluids |
| 01/23/1990 | CA1264688A1 Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
| 01/23/1990 | CA1264687A1 Recombinant plasmid and microbial strain transformed by said plasmid |
| 01/23/1990 | CA1264686A1 Portable inducible control system |
| 01/23/1990 | CA1264685A1 Identification of genes in pseudomonas bacteria |
| 01/18/1990 | DE3823451A1 Recombinant DNA, microorganisms transformed therewith, and process for the preparation of L-lysine using these microorganisms |
| 01/17/1990 | EP0351322A1 Transformed Shigella |
| 01/17/1990 | EP0351313A2 Novel glycoprotein and gene coding therefor |
| 01/17/1990 | EP0351246A2 A tissue plasminogen activator analogue |
| 01/17/1990 | EP0351244A2 Antibodies and methods for immunochemical assay using them |
| 01/17/1990 | EP0351045A2 Monoclonal antibody NUH2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 01/17/1990 | EP0351029A1 Novel glucose isomerase enzymes and their use |
| 01/17/1990 | EP0350715A1 Recombinant treponema hyodysenteriae antigen and uses therefor |
| 01/17/1990 | EP0350692A1 Polypeptides, their preparation and their use |
| 01/17/1990 | EP0350506A1 Pulmonary surfactant protein and related polypeptide |
| 01/17/1990 | EP0155950B1 Oligonucleotide polymeric support system |
| 01/17/1990 | CN1038837A Recombinant coccidiosis vaccines |
| 01/16/1990 | US4894443 Polypeptides, antibodies |
| 01/16/1990 | US4894442 Monoclonal antibodies that bind to alpha-acid glycoprotein |
| 01/16/1990 | US4894440 Method of isolating megakaryocyte stimulatory factor |
| 01/16/1990 | US4894436 Genetic engineering, polypeptides |